| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . 810 . 820 . 830 . 840 . 850 . 860 . 870 . 880 . 890 . 900 . |
# |
Score |
Template |
Links and tools | %id | First |
MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLTEPPKLLPQIDIVNISDSFEMTYRFCSQFSKGVYAIFGFYERRTVNMLTSFCGALHVCFITPSFPVDTSNQFVLQLRPELQDALISIIDHYKWQKFVYIYDADRGLSVLQKVLDTAAEKNWQVTAVNILTTTEEGYRMLFQDLEKKKERLVVVDCESERLNAILGQIIKLEKNGIGYHYILANLGFMDIDLNKFKESGANVTGFQLVNYTDTIPAKIMQQWKNSDARDHTRVDWKRPKYTSALTYDGVKVMAEAFQSLRRQRIDISRRGNAGDCLANPAVPWGQGIDIQRALQQVRFEGLTGNVQFNEKGRRTNYTLHVIEMKHDSIRKIGYWNEDDKFVPAATDAQAGGDNSSVQNRTYIVTTILEDPYVMLKKNANQFEGNDRYEGYCVELAAEIAKHVGYSYRLEIVSDGKYGARDPDTKAWNGMVGELVYGRADVAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHSEEFEEGRDQTTSDQSNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIAYGTLEAGSTKEFFRRSKIAVFEKMWTYMKSAEPSVFVRTTEEGMIRVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSALRNPVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKDKTSALSLSNVAGVFYILIGGLGLAMLVALIEFCYKSRSESKRMKGFCLIPQQSINEAIRTSTLPRNSGAGASSGGSGENGRVVSHDFPKSMQSIPCMSHSSGMPLGATGL | Last |
1 | -81.400 | PF00060.26; B7ZPS4_XENLA/162-426; Ligand-gated ion channel |
ali follow.. |
34 | 1 | .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SKETWIGILVAYMVTSLCLFLVGRLSPCEWTELSTE----------QNNFTFLNSLWFGAGAFTLQGAEPHPKSVSARIIAVIWWIFSIVLVAAYIASFAAFLNSDSVQTTIQTFEDLVNQRTLEFGTINSSSTFQFFKNSKNPTYRMIYEYMDKRKDELLVKSFAEGVRRVRE--SNYAFLGESVMQDIMVAK-HCELARAPQIIAGRGYGIAASIDSQLIKQLSIAILEQTESGNIEYLRKKWWDNTCSM-----KRSAGWNPVQPHTLGGIFLILGIGL......................................................................................... |
265 |
2 | -53.100 | PF10613.9; H3CIB5_TETNG/416-530; Ligated ion channel L-glutamate- and glycine-binding site |
ali follow.. |
56 | 1 | ......................................................................................................................................................................................................................................................................................................................................................................................................................KTLIVTTILENPYVMRKDNYQDFQGNDQYEGFCVDMLREVADILKFSFKIKLVDDGLYGAPEP-NGSWTGMVGELINRKADLAVAAFTITSEREKVIDFSKPFMTLGISILYRVQ................................................................................................................................................................................................................................................................................................................................................................................................. |
114 |
3 | -42.800 | PF01094.28; GLR24_ARATH/47-394; Receptor family ligand binding region |
ali follow.. |
15 | 1 | ....................................LSLLAINMSLSDFYSSTRLLLNFADSRDDVVGAAAAALDLIKNKEVKAILGPRTTMQASFVIEVGQKSQVPIISFSATSPFLDPYFFRSTYDQVQAISEIIKVFGWREVVPVYENNAGEGIMPGLTDALQAINIRIPYRTVISATDDEISVDLLKLMTKPTRVFVVHMNRFLASRVFSKARETGLMKQGYAWILTNGVIDHLVLMNDIEAMQGVIGIRTHFPISEELQTFRSRLAKAFPVSEL-------NIYGLRAYDATTALAMAVEEAGTTNLTFSKMDGRNISDLEALSVSEYGPKLIRSLSQIQFKGLSGDYHFVDGQLHAS-VFEIVNVIDGG................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
348 |
4 | -25.000 | PF00497.20; A6X2Q5_OCHA4/44-271; Bacterial extracellular solute-binding proteins, family 3 |
ali follow.. |
16 | 13 | ...........................................................................................................................................................................................................................................................................................................................................................................................................................................VYMKDGKPAGFDVELMEGVAKQLGLAAEFK-------------DTRFTSLITGARANHFDVIASALYVTPERQKILNFI-PYIKAGSSLLVLKDAKFR-------------------------------------------------------------------------------------------------------------------------PANEKELCGK---IIGSMQGASWLPKLKALSEDYCAKNNLGAIETREFDTDAQVTQAL----RSGSVDVEFMDNVVAAELLKKFPDDYAVTSSLIYPIMVGVATTPQNKLFNAMNDAFAQMRKDGSYDALVKTYGME........................................................................................................................... |
228 |
5 | -14.500 | PF13458.6; Q2J527_FRACC/75-422; Periplasmic binding protein |
ali follow.. |
9 | 1 | .......................EIKAGVLFPDTGPFARAGIDARFGEANAAGGV--KIVYSWRDDVSDPQLNLAAVQKEEVFGIIEGLGAVSG--SAQYLADLNVPIVGLGAEPVHENMVSWHHYTVPAGSSTVWGDFIR-RSAMVDVALNAVHDYHRQLVDSLQAAGVSVDINFEVTAETTSFEALARQMKAANIDTLTGVITPDVLTQILPAARAAGVNLKTVLLSLGYDRALLTDLGPALAGTNIYISFVPFELNTPAHQRLLAAMTRYSPQTQPPE-----QESAVFGWLSADLFLHGLQAAGAC----------------------THQSFLQGLHSVH---LPKPVDLAKNRGQLGNCYYFMRISGDG................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
347 |
6 | -14.100 | PF13433.6; A4YPA8_BRASO/30-401; Periplasmic binding protein domain |
ali follow.. |
8 | 1 | ........................IKIGILHSLSETILKDLMLMQVAEQNARKKIEPVVVDPASNWPLFAEKARELLVKDKVAAVFGCWTSVSRKSVLPVFEELNGLLYYPLEYEGEESYNIFYGSSVPDNKAVPAVDYLEVKRFVLEGTDYVYPRTSNKIIRAYLKTADDDIMENYTPFGFSDWQTEVAAIKKFGGSAVISTVNGDANVPFYKELGNQGVKAKDIPVIAFSVGEEELAGLDTKPQVGHLAAWSYFQSNTPENKAFIAKWRDYA-----KNPKRVTNDPMESAYILFHMWVQAVQQAGTADV----------------------DAVRQAMIGQKFKSPSGFEVVMGSNHHMAKPVMIGEIQSNGQFTI............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
354 |
7 | -10.900 | PF04348.13; LPOA_HAEIN/39-568; LppC putative lipoprotein |
ali follow.. |
11 | 207 | ............LLTLLNFQQTNVSQIGLLLPLSGDGQITTIQSGFNDAKGNSTIPVQVFDTSMNSVQDIIAQA---KQAGIKTLVGPLKQNLDVILADPAQIQGMDVLALNATPNSRAICYYGLSPEEAESAANKMWNDGVRNPLVAMQNDLGQRVGNAFNVRWQQLAGTDANIRYYNLPADVTYFVQENNSNTTA--LYAVASPTELAEMKGYLTNIVPN------IYASSRASASATNTNTDFIAQMNGVQFKDTNSPQYQKLAKSTGGEYQLMR-----------YAMGADAWLLINQFNE--------------------------------LRQVPGYRLSGLTGILSADTNCN.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
517 |
8 | -6.790 | PF07885.16; Q8U058_PYRFU/403-481; Ion channel |
ali follow.. |
16 | 25 | .........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SPLDYVYFSIVTATTLGGDIHPTGV-GKAIASAEAIFGMFMWAVFLTVFARKYM........................................................................................................................................................................................................................................................................... |
78 |
9 | -5.980 | PF11847.8; V5X6I4_MYCNE/1-670; Alpha-(1 |
ali follow.. |
12 | 45 | ...............................................................................................................................................................................................................................................................................................................................................................................................................................................QNQAYGYLFPHFFLAGDLLGVP----------------TQRLWWALLLTVGFWGLLRVAEALGIGTTAARVV--------AAGAFAL------SPRVLTTLGAISSETLPMMLAPWVLLPVIYVLRGDPRIRLLAARSA-ALMGAVNAVATLTGCLAAIIWWAAHKPNRQWWRFTGWWLGCTALAVTWWAVALVLLGRISPPFLDYIESSGVTTRWLSLTEMLR------GT---DSWTPFVAPTATAGSPLVTGSVAVLATTLVAAAGLAGLAMASMPSRGRLIL----------------ILFVGVTALAVGYGLGSPIAAGVQLFLDADGTPLRNVHKLEPL.................................................................................................................................. |
343 |
10 | -5.880 | PF00946.19; Q6YIR9_FDLV8/10-1113; Mononegavirales RNA dependent RNA polymerase |
ali follow.. |
8 | 276 | ......................EPLALSYIQLRDPILDQLLKEDTILSTGEVKDFIELISEIINMGSVSEISEIFSFFRDKVRDHMCKPKVLDYETLQKGHAVFCSMIINGFRERHGGSWPPCFLPDYASSELKAVMAN-SFIGFK--FDKFEEVNLDEDLTIFMKDKALSPIRAEWDTVYPQENMQYSPGRSSTSRRLVFLEDMEFNPQDIIDYVVSGSYLIDQDFNISYSLKEKEIKQAGRLFAKMTYKMRAAQVLAESLVAHGVGKYFQENGMVKDEHELLKSLTTLSLAGVPRSRPGEDPSATEESKFVKIAQKGKEILRNNQTRRSTQESRDQDGLANEKHETVASFITTDLQKWRYESVILFAQRLDEIYGLPGFFEWLHKRLEKSVLYVADPNCPPDFRTKMSLEDTPDTGIFIHNPMG--------IEGYSISMIHLAAVQTGVRVSAVIQGDNQ-------------AVTTRVPVRMNYNQKKTECYKSTIRYFELRKVMGGLGHNL---KLNETSNQFFIYSKRIYFD---------SILPQGLKTISRCVF-----------------WSETLVDETRAACSNISTSLAKAVENGISPLLCYLLNAWKTLQQLHISLAFSINPTITKDLYGPILSSQDWMIIAVIVPSQLGGFNYMSLSRLFVRNIGDPLVAALADVKRYEIGLLTTAALTKFTTQVPGDSTELDWASDPYLSKSPNPMLEGLFHENTDEEDHDLARFLIDREIILPRVANVILDQSVTGARSAIAGLLDTTKTLIKNTANKGGLSNRTVS........................................................................................................ |
1087 |